Jacques Biot, past president of the Ecole Polytechnique in France, provided a presentation on artificial intelligence (AI) and healthcare. According to Biot, the utilization of deep learning in healthcare, including dermatology, have flourished in the area of diagnosis, but are less common in therapeutic applications. Biot also discussed the application of AI in care provision organization, but points to deficiencies in these deep learning systems that can create biases when used to manage patients. However, Biot emphasized the role of AI in clinical research, which can be used to select and stratify patients. He also discussed the assessment methodology used by the United States Food and Drug Administration (FDA) to evaluate artificial intelligence used for healthcare purposes, noting that the FDA has approved between 50 and 64 algorithms so far. Biot also covered methodological and technical challenges to overcome in the future of AI and clinical research. In regard to societal concerns regarding the use of AI in healthcare, specifically the concerns associated with preserving the physician-patient relationship, Biot proposes that advances in the use of AI in healthcare will allow for more time for physicians to focus on the patient-physician relationship, thus strengthening this area of healthcare.